Skip to content
Industry
This is research, not advice. We’re not SEBI-registered.

ICON Public Limited share price today

ICON Public Limited Company · ICLR · Healthcare · Diagnostics & Research · price as of the 4 November 2026 close, updated every trading day · results updated weekly · All US stock lists

ICON Public Limited share price: $203.11 at the close on 4 November 2026, +27.6% in a year.

Getting worseBusiness trend from the last 12 quarters
$203.11Price +27.6% in a year
36.3×P/E over 4.6 years
$2.1 BRevenue (Jun 2026) +1.2% on a year ago
$72.6 MProfit (Jun 2026) −64.3% on a year ago
9.4%Operating margin −4.4 points on a year ago
2%ROE FY25
1.6%ROIC against a 9.7% cost of capital: −8.1 points

ICON Public Limited Company's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer.

The main question: the share price moved +27.6% in a year while yearly earnings per share moved −69.0%. The difference came from the market paying a higher multiple.

The price has been stalling near its high for 20 weeks. Over the last four quarters, results have been deteriorating, with profit −64.3% on a year earlier, and 239% of the last 3 years' profit came in as cash. What will decide it: whether earnings grow into a price that has already moved.

What is the ICON Public Limited share price today?

ICON Public Limited Company's share price was $203.11 at the close on 4 November 2026. It has been stalling near its high for 20 weeks. That is 39.0% above its average price over the last 200 trading days.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today ICON Public Limited Company is in stage 3. The phase helps read everything below.

In the last 52 weeks it traded between $93 and $211, and at that close it sat 93% of the way up from that low. Over the past 13 weeks it has done better than the S&P 500, and it has stayed ahead for 3 weeks in a row.

1Y

Nov 2026: $203.11, 39.0% above its 200-day average. The price has been stalling near its high for 20 weeks.

  • Price $203.11
  • 50-day avg $173.91
  • 200-day avg $146.16
Nov 2026: $203.11, 39.0% above its 200-day average. The price has been stalling near its high for 20 weeks.
WeekPrice50-day avg200-day avg
31 Oct 2025$171.82$178.12$167.30
7 Nov 2025$159.14$177.04$166.32
14 Nov 2025$162.18$175.50$165.34
21 Nov 2025$164.56$174.24$164.44
28 Nov 2025$185.00$174.43$164.18
5 Dec 2025$185.87$175.97$164.04
12 Dec 2025$186.58$176.74$163.75
19 Dec 2025$173.77$175.80$163.59
26 Dec 2025$182.84$175.51$163.60
2 Jan 2026$188.67$175.13$163.60
9 Jan 2026$181.38$176.36$163.87
16 Jan 2026$182.61$177.93$164.04
23 Jan 2026$186.70$179.81$164.53
30 Jan 2026$180.25$182.19$165.52
6 Feb 2026$150.59$182.16$166.03
13 Feb 2026$93.00$176.15$165.42
20 Feb 2026$99.70$168.98$164.42
27 Feb 2026$108.14$160.90$163.61
6 Mar 2026$107.20$153.93$163.01
13 Mar 2026$98.33$145.99$162.37
20 Mar 2026$99.70$136.39$161.56
27 Mar 2026$102.08$128.17$160.60
2 Apr 2026$114.19$122.47$159.88
10 Apr 2026$106.81$114.50$158.93
17 Apr 2026$119.68$108.49$158.15
24 Apr 2026$102.17$105.05$157.18
1 May 2026$112.85$106.98$156.23
8 May 2026$124.49$108.81$155.47
15 May 2026$116.38$109.72$153.74
22 May 2026$116.78$110.70$152.51
29 May 2026$136.07$112.94$151.81
5 Jun 2026$149.45$117.38$150.99
12 Jun 2026$146.18$121.63$150.33
18 Jun 2026$146.00$124.49$149.71
26 Jun 2026$169.86$128.87$149.18
2 Jul 2026$173.06$133.42$149.23
10 Jul 2026$167.72$139.66$149.07
17 Jul 2026$170.00$144.97$149.17
24 Jul 2026$165.76$149.40$148.62
31 Jul 2026$163.56$154.96$148.25
7 Aug 2026$164.51$159.43$147.60
14 Aug 2026$163.15$162.18$147.11
21 Aug 2026$172.23$164.27$147.14
28 Aug 2026$170.02$166.68$147.38
4 Sep 2026$164.85$168.00$147.41
11 Sep 2026$169.31$167.22$147.46
18 Sep 2026$164.11$167.27$147.27
25 Sep 2026$172.33$167.33$146.88
2 Oct 2026$162.05$167.31$146.44
9 Oct 2026$164.17$166.60$146.09
16 Oct 2026$170.18$167.39$145.73
23 Oct 2026$185.27$168.74$145.35
30 Oct 2026$211.36$171.97$145.80
4 Nov 2026$203.11$173.91$146.16
Weekly closing price ($) with its 50-day and 200-day averages. The strip under the chart shows the phase: tan sideways, green rising, yellow stalling near a high, orange falling. 1-year window.

3Y

Nov 2026: $203.11, 39.0% above its 200-day average. The price has been stalling near its high for 20 weeks.

  • Price $203.11
  • 50-day avg $173.91
  • 200-day avg $146.16
Nov 2026: $203.11, 39.0% above its 200-day average. The price has been stalling near its high for 20 weeks.
WeekPrice50-day avg200-day avg
3 Nov 2023$258.11$248.09$231.33
10 Nov 2023$256.34$247.74$231.92
17 Nov 2023$269.95$248.64$232.76
24 Nov 2023$271.89$249.55$233.37
1 Dec 2023$269.35$250.32$234.20
8 Dec 2023$272.46$252.37$235.30
15 Dec 2023$279.03$255.87$236.57
22 Dec 2023$280.60$259.73$237.86
29 Dec 2023$283.07$263.34$239.29
5 Jan 2024$270.72$266.88$240.52
12 Jan 2024$255.00$269.48$241.90
19 Jan 2024$259.57$269.34$242.71
26 Jan 2024$266.51$270.27$244.11
2 Feb 2024$260.50$269.62$245.39
9 Feb 2024$278.48$269.63$246.99
16 Feb 2024$289.03$271.35$249.27
23 Feb 2024$314.19$273.59$251.51
1 Mar 2024$325.51$278.00$254.64
8 Mar 2024$334.64$283.32$257.76
15 Mar 2024$334.76$288.72$260.95
22 Mar 2024$332.00$295.32$263.85
28 Mar 2024$335.95$301.65$265.97
5 Apr 2024$318.83$307.66$268.21
12 Apr 2024$306.00$312.62$270.37
19 Apr 2024$288.23$315.50$271.61
26 Apr 2024$308.31$317.98$273.22
3 May 2024$309.02$319.04$274.62
10 May 2024$315.39$318.48$276.28
17 May 2024$314.72$316.67$277.94
24 May 2024$320.72$315.11$279.59
31 May 2024$324.82$313.92$280.82
7 Jun 2024$319.28$313.00$282.59
14 Jun 2024$313.33$312.27$284.14
21 Jun 2024$318.78$312.23$285.26
28 Jun 2024$313.47$313.60$286.73
5 Jul 2024$320.77$315.38$287.84
12 Jul 2024$336.03$317.86$289.67
19 Jul 2024$329.70$320.61$291.90
26 Jul 2024$323.46$322.07$294.11
2 Aug 2024$317.08$322.94$296.13
9 Aug 2024$312.93$322.29$298.22
16 Aug 2024$322.49$321.78$300.30
23 Aug 2024$324.16$322.15$302.07
30 Aug 2024$322.06$322.75$303.74
6 Sep 2024$302.52$322.18$304.54
13 Sep 2024$300.00$319.96$305.11
20 Sep 2024$303.07$317.28$305.90
27 Sep 2024$285.61$312.55$306.37
4 Oct 2024$293.54$308.67$306.69
11 Oct 2024$296.65$305.17$306.95
18 Oct 2024$297.72$303.53$307.33
25 Oct 2024$220.47$297.76$307.09
1 Nov 2024$220.40$288.12$306.44
8 Nov 2024$214.93$277.82$305.35
15 Nov 2024$189.64$267.03$303.85
22 Nov 2024$214.25$257.93$302.24
29 Nov 2024$210.25$251.14$300.88
6 Dec 2024$217.47$243.18$298.91
13 Dec 2024$208.15$235.61$296.25
20 Dec 2024$207.51$226.88$293.03
27 Dec 2024$212.29$220.23$290.58
3 Jan 2025$213.28$213.83$288.13
10 Jan 2025$218.22$212.28$285.83
17 Jan 2025$198.11$210.21$282.68
24 Jan 2025$200.48$208.83$280.36
31 Jan 2025$199.08$208.54$277.63
7 Feb 2025$193.46$207.76$275.19
14 Feb 2025$186.21$205.12$272.21
21 Feb 2025$201.39$203.70$270.08
28 Feb 2025$190.02$201.82$267.08
7 Mar 2025$186.56$199.88$263.83
14 Mar 2025$184.58$196.80$260.39
21 Mar 2025$184.87$193.83$257.00
28 Mar 2025$179.07$190.75$253.46
4 Apr 2025$153.72$187.08$249.68
11 Apr 2025$144.04$181.69$245.43
17 Apr 2025$139.32$177.50$242.02
25 Apr 2025$144.96$172.58$237.55
2 May 2025$142.96$168.25$232.79
9 May 2025$133.96$162.36$227.92
16 May 2025$131.63$157.26$223.16
23 May 2025$127.99$152.00$218.40
30 May 2025$130.28$147.65$214.80
6 Jun 2025$139.11$142.96$210.14
13 Jun 2025$145.66$140.02$205.69
20 Jun 2025$146.48$139.39$202.13
27 Jun 2025$144.56$139.37$198.13
3 Jul 2025$150.10$140.14$195.25
11 Jul 2025$150.52$140.61$191.54
18 Jul 2025$143.54$140.85$187.95
25 Jul 2025$187.01$144.03$184.94
1 Aug 2025$166.44$148.73$182.08
8 Aug 2025$158.44$151.90$178.70
15 Aug 2025$175.84$155.75$176.51
22 Aug 2025$175.83$159.47$175.29
29 Aug 2025$177.94$162.38$174.15
5 Sep 2025$174.88$164.80$173.56
12 Sep 2025$175.00$167.31$172.92
19 Sep 2025$174.00$169.72$171.95
26 Sep 2025$163.79$171.69$170.79
3 Oct 2025$193.89$173.89$170.04
10 Oct 2025$183.49$174.33$169.60
17 Oct 2025$185.06$176.79$168.97
24 Oct 2025$178.11$178.66$168.26
31 Oct 2025$171.82$178.12$167.30
7 Nov 2025$159.14$177.04$166.32
14 Nov 2025$162.18$175.50$165.34
21 Nov 2025$164.56$174.24$164.44
28 Nov 2025$185.00$174.43$164.18
5 Dec 2025$185.87$175.97$164.04
12 Dec 2025$186.58$176.74$163.75
19 Dec 2025$173.77$175.80$163.59
26 Dec 2025$182.84$175.51$163.60
2 Jan 2026$188.67$175.13$163.60
9 Jan 2026$181.38$176.36$163.87
16 Jan 2026$182.61$177.93$164.04
23 Jan 2026$186.70$179.81$164.53
30 Jan 2026$180.25$182.19$165.52
6 Feb 2026$150.59$182.16$166.03
13 Feb 2026$93.00$176.15$165.42
20 Feb 2026$99.70$168.98$164.42
27 Feb 2026$108.14$160.90$163.61
6 Mar 2026$107.20$153.93$163.01
13 Mar 2026$98.33$145.99$162.37
20 Mar 2026$99.70$136.39$161.56
27 Mar 2026$102.08$128.17$160.60
2 Apr 2026$114.19$122.47$159.88
10 Apr 2026$106.81$114.50$158.93
17 Apr 2026$119.68$108.49$158.15
24 Apr 2026$102.17$105.05$157.18
1 May 2026$112.85$106.98$156.23
8 May 2026$124.49$108.81$155.47
15 May 2026$116.38$109.72$153.74
22 May 2026$116.78$110.70$152.51
29 May 2026$136.07$112.94$151.81
5 Jun 2026$149.45$117.38$150.99
12 Jun 2026$146.18$121.63$150.33
18 Jun 2026$146.00$124.49$149.71
26 Jun 2026$169.86$128.87$149.18
2 Jul 2026$173.06$133.42$149.23
10 Jul 2026$167.72$139.66$149.07
17 Jul 2026$170.00$144.97$149.17
24 Jul 2026$165.76$149.40$148.62
31 Jul 2026$163.56$154.96$148.25
7 Aug 2026$164.51$159.43$147.60
14 Aug 2026$163.15$162.18$147.11
21 Aug 2026$172.23$164.27$147.14
28 Aug 2026$170.02$166.68$147.38
4 Sep 2026$164.85$168.00$147.41
11 Sep 2026$169.31$167.22$147.46
18 Sep 2026$164.11$167.27$147.27
25 Sep 2026$172.33$167.33$146.88
2 Oct 2026$162.05$167.31$146.44
9 Oct 2026$164.17$166.60$146.09
16 Oct 2026$170.18$167.39$145.73
23 Oct 2026$185.27$168.74$145.35
30 Oct 2026$211.36$171.97$145.80
4 Nov 2026$203.11$173.91$146.16
Weekly closing price ($) with its 50-day and 200-day averages. The strip under the chart shows the phase: tan sideways, green rising, yellow stalling near a high, orange falling. 3-year window.

5Y

Nov 2026: $203.11, 39.0% above its 200-day average. The price has been stalling near its high for 20 weeks.

  • Price $203.11
  • 50-day avg $173.91
  • 200-day avg $146.16
Nov 2026: $203.11, 39.0% above its 200-day average. The price has been stalling near its high for 20 weeks.
WeekPrice50-day avg200-day avg
29 Oct 2021$286.77$266.75$225.33
12 Nov 2021$285.55$271.51$228.54
26 Nov 2021$272.00$274.77$231.97
10 Dec 2021$277.10$275.31$235.59
23 Dec 2021$307.93$279.78$240.64
7 Jan 2022$280.68$283.47$246.32
21 Jan 2022$251.95$281.73$249.50
4 Feb 2022$267.03$278.04$252.48
18 Feb 2022$226.84$274.33$254.34
4 Mar 2022$226.32$265.10$254.53
18 Mar 2022$239.50$250.03$254.57
1 Apr 2022$246.63$243.69$255.80
14 Apr 2022$246.04$241.67$257.43
29 Apr 2022$226.21$235.64$258.43
13 May 2022$211.00$233.15$258.33
27 May 2022$227.30$230.98$256.96
10 Jun 2022$219.24$228.11$256.07
24 Jun 2022$220.63$220.77$253.79
8 Jul 2022$217.95$216.93$251.71
22 Jul 2022$221.09$214.92$248.89
5 Aug 2022$233.12$219.04$246.97
19 Aug 2022$233.68$222.26$244.82
2 Sep 2022$206.74$223.70$241.82
16 Sep 2022$204.49$223.19$239.03
30 Sep 2022$183.78$218.73$234.79
14 Oct 2022$173.90$209.76$229.22
28 Oct 2022$199.25$199.23$224.01
11 Nov 2022$221.46$195.70$221.21
25 Nov 2022$219.00$196.14$218.90
9 Dec 2022$194.77$199.16$217.22
23 Dec 2022$194.85$200.60$215.44
6 Jan 2023$200.45$202.97$214.02
20 Jan 2023$231.42$207.53$213.14
3 Feb 2023$244.02$211.45$212.39
17 Feb 2023$227.57$215.81$212.69
3 Mar 2023$233.88$221.50$213.17
17 Mar 2023$207.75$226.20$213.32
31 Mar 2023$213.59$224.67$212.73
14 Apr 2023$209.78$220.85$212.70
28 Apr 2023$192.69$214.11$212.16
12 May 2023$200.00$207.20$210.84
26 May 2023$203.69$204.65$209.56
9 Jun 2023$221.93$206.57$208.73
23 Jun 2023$226.33$210.08$209.46
7 Jul 2023$236.44$215.44$210.53
21 Jul 2023$245.93$226.44$213.37
4 Aug 2023$253.35$235.09$216.60
18 Aug 2023$250.34$243.30$219.95
1 Sep 2023$262.69$248.81$222.60
15 Sep 2023$261.71$252.54$224.41
29 Sep 2023$246.25$254.24$226.79
13 Oct 2023$247.24$252.98$229.25
27 Oct 2023$235.31$248.32$230.76
10 Nov 2023$256.34$247.74$231.92
24 Nov 2023$271.89$249.55$233.37
8 Dec 2023$272.46$252.37$235.30
22 Dec 2023$280.60$259.73$237.86
5 Jan 2024$270.72$266.88$240.52
19 Jan 2024$259.57$269.34$242.71
2 Feb 2024$260.50$269.62$245.39
16 Feb 2024$289.03$271.35$249.27
1 Mar 2024$325.51$278.00$254.64
15 Mar 2024$334.76$288.72$260.95
28 Mar 2024$335.95$301.65$265.97
12 Apr 2024$306.00$312.62$270.37
26 Apr 2024$308.31$317.98$273.22
10 May 2024$315.39$318.48$276.28
24 May 2024$320.72$315.11$279.59
7 Jun 2024$319.28$313.00$282.59
21 Jun 2024$318.78$312.23$285.26
5 Jul 2024$320.77$315.38$287.84
19 Jul 2024$329.70$320.61$291.90
2 Aug 2024$317.08$322.94$296.13
16 Aug 2024$322.49$321.78$300.30
30 Aug 2024$322.06$322.75$303.74
13 Sep 2024$300.00$319.96$305.11
27 Sep 2024$285.61$312.55$306.37
11 Oct 2024$296.65$305.17$306.95
25 Oct 2024$220.47$297.76$307.09
8 Nov 2024$214.93$277.82$305.35
22 Nov 2024$214.25$257.93$302.24
6 Dec 2024$217.47$243.18$298.91
20 Dec 2024$207.51$226.88$293.03
3 Jan 2025$213.28$213.83$288.13
17 Jan 2025$198.11$210.21$282.68
31 Jan 2025$199.08$208.54$277.63
14 Feb 2025$186.21$205.12$272.21
28 Feb 2025$190.02$201.82$267.08
14 Mar 2025$184.58$196.80$260.39
28 Mar 2025$179.07$190.75$253.46
11 Apr 2025$144.04$181.69$245.43
25 Apr 2025$144.96$172.58$237.55
9 May 2025$133.96$162.36$227.92
23 May 2025$127.99$152.00$218.40
6 Jun 2025$139.11$142.96$210.14
20 Jun 2025$146.48$139.39$202.13
3 Jul 2025$150.10$140.14$195.25
18 Jul 2025$143.54$140.85$187.95
1 Aug 2025$166.44$148.73$182.08
15 Aug 2025$175.84$155.75$176.51
29 Aug 2025$177.94$162.38$174.15
12 Sep 2025$175.00$167.31$172.92
26 Sep 2025$163.79$171.69$170.79
10 Oct 2025$183.49$174.33$169.60
24 Oct 2025$178.11$178.66$168.26
7 Nov 2025$159.14$177.04$166.32
21 Nov 2025$164.56$174.24$164.44
5 Dec 2025$185.87$175.97$164.04
19 Dec 2025$173.77$175.80$163.59
2 Jan 2026$188.67$175.13$163.60
16 Jan 2026$182.61$177.93$164.04
30 Jan 2026$180.25$182.19$165.52
13 Feb 2026$93.00$176.15$165.42
27 Feb 2026$108.14$160.90$163.61
13 Mar 2026$98.33$145.99$162.37
27 Mar 2026$102.08$128.17$160.60
10 Apr 2026$106.81$114.50$158.93
24 Apr 2026$102.17$105.05$157.18
8 May 2026$124.49$108.81$155.47
22 May 2026$116.78$110.70$152.51
5 Jun 2026$149.45$117.38$150.99
18 Jun 2026$146.00$124.49$149.71
2 Jul 2026$173.06$133.42$149.23
17 Jul 2026$170.00$144.97$149.17
31 Jul 2026$163.56$154.96$148.25
14 Aug 2026$163.15$162.18$147.11
28 Aug 2026$170.02$166.68$147.38
11 Sep 2026$169.31$167.22$147.46
25 Sep 2026$172.33$167.33$146.88
9 Oct 2026$164.17$166.60$146.09
23 Oct 2026$185.27$168.74$145.35
4 Nov 2026$203.11$173.91$146.16
Weekly closing price ($) with its 50-day and 200-day averages. The strip under the chart shows the phase: tan sideways, green rising, yellow stalling near a high, orange falling. 5-year window.

10Y

Nov 2026: $203.11, 39.0% above its 200-day average. The price has been stalling near its high for 20 weeks.

  • Price $203.11
  • 50-day avg $173.91
  • 200-day avg $146.16
Nov 2026: $203.11, 39.0% above its 200-day average. The price has been stalling near its high for 20 weeks.
WeekPrice50-day avg200-day avg
28 Oct 2016$80.32$77.52–
18 Nov 2016$76.21$78.26–
9 Dec 2016$76.43$78.19–
30 Dec 2016$75.20$77.66–
20 Jan 2017$80.07$77.56–
10 Feb 2017$86.43$79.14–
3 Mar 2017$83.47$81.66–
24 Mar 2017$78.94$82.52–
13 Apr 2017$77.58$81.97–
5 May 2017$85.96$80.77$78.92
26 May 2017$91.73$82.78$79.91
16 Jun 2017$92.99$87.30$81.27
7 Jul 2017$98.24$92.41$82.72
28 Jul 2017$102.84$96.45$84.44
18 Aug 2017$104.99$99.81$86.24
8 Sep 2017$115.10$104.09$88.53
29 Sep 2017$113.88$108.21$91.26
20 Oct 2017$113.63$111.49$94.15
10 Nov 2017$113.81$115.03$96.97
1 Dec 2017$116.55$115.75$99.12
22 Dec 2017$113.59$115.57$101.33
12 Jan 2018$113.27$115.33$103.64
2 Feb 2018$106.93$113.79$105.95
23 Feb 2018$114.89$112.51$107.83
16 Mar 2018$122.21$113.85$109.96
6 Apr 2018$111.38$114.57$111.44
27 Apr 2018$118.50$117.25$113.00
18 May 2018$125.74$119.48$114.54
8 Jun 2018$133.79$121.60$116.23
29 Jun 2018$132.53$126.99$117.89
20 Jul 2018$140.14$131.76$119.56
10 Aug 2018$147.55$136.98$121.67
31 Aug 2018$149.02$140.35$123.67
21 Sep 2018$150.25$144.02$125.87
12 Oct 2018$144.92$146.72$128.54
2 Nov 2018$137.33$145.42$130.46
23 Nov 2018$133.82$142.34$132.25
14 Dec 2018$133.50$139.55$134.18
4 Jan 2019$123.64$134.52$134.59
25 Jan 2019$135.60$133.17$135.77
15 Feb 2019$145.05$134.39$137.41
8 Mar 2019$128.28$136.24$138.62
29 Mar 2019$136.58$137.57$138.99
18 Apr 2019$130.97$137.58$139.16
10 May 2019$139.73$135.91$139.19
31 May 2019$141.56$137.27$138.91
21 Jun 2019$147.64$139.47$138.81
12 Jul 2019$149.04$144.16$139.13
2 Aug 2019$154.41$149.03$139.64
23 Aug 2019$153.41$153.01$140.79
13 Sep 2019$149.92$154.00$142.01
4 Oct 2019$147.86$153.07$142.82
25 Oct 2019$148.91$149.33$144.04
15 Nov 2019$154.59$147.54$145.09
6 Dec 2019$162.90$149.92$146.29
27 Dec 2019$171.88$156.00$148.37
17 Jan 2020$175.78$162.76$150.81
7 Feb 2020$168.92$168.35$153.34
28 Feb 2020$156.06$170.24$155.49
20 Mar 2020$121.24$163.24$155.98
9 Apr 2020$153.41$153.04$155.33
1 May 2020$154.15$147.77$155.55
22 May 2020$166.51$147.48$155.74
12 Jun 2020$158.07$157.04$156.38
2 Jul 2020$166.91$160.62$157.10
24 Jul 2020$185.06$168.58$159.51
14 Aug 2020$187.92$175.56$162.84
4 Sep 2020$178.00$183.09$165.55
25 Sep 2020$183.14$185.72$166.98
16 Oct 2020$203.88$189.94$169.57
6 Nov 2020$199.32$191.42$171.20
27 Nov 2020$191.14$193.10$172.44
18 Dec 2020$194.19$195.07$174.80
8 Jan 2021$214.75$193.66$178.85
29 Jan 2021$203.81$199.87$183.75
19 Feb 2021$208.21$203.41$187.29
12 Mar 2021$182.28$200.05$189.04
1 Apr 2021$202.33$194.70$190.73
23 Apr 2021$217.82$193.67$193.64
14 May 2021$229.20$201.70$196.43
4 Jun 2021$220.48$213.81$198.99
25 Jun 2021$217.15$219.19$201.30
16 Jul 2021$217.29$218.94$203.43
6 Aug 2021$241.74$219.81$205.35
27 Aug 2021$253.71$227.38$209.27
17 Sep 2021$268.19$240.80$214.26
8 Oct 2021$265.26$256.11$219.65
29 Oct 2021$286.77$266.75$225.33
19 Nov 2021$286.20$273.86$230.58
10 Dec 2021$277.10$275.31$235.59
31 Dec 2021$309.70$282.98$243.79
21 Jan 2022$251.95$281.73$249.50
11 Feb 2022$261.56$277.80$253.83
4 Mar 2022$226.32$265.10$254.53
25 Mar 2022$238.63$245.35$255.05
14 Apr 2022$246.04$241.67$257.43
6 May 2022$224.31$235.79$258.76
27 May 2022$227.30$230.98$256.96
17 Jun 2022$200.87$224.05$254.77
8 Jul 2022$217.95$216.93$251.71
29 Jul 2022$241.25$217.23$248.05
19 Aug 2022$233.68$222.26$244.82
9 Sep 2022$226.20$223.59$240.52
30 Sep 2022$183.78$218.73$234.79
21 Oct 2022$177.99$204.20$226.32
11 Nov 2022$221.46$195.70$221.21
2 Dec 2022$213.07$197.84$217.90
23 Dec 2022$194.85$200.60$215.44
13 Jan 2023$224.49$205.10$213.47
3 Feb 2023$244.02$211.45$212.39
24 Feb 2023$223.50$217.90$212.69
17 Mar 2023$207.75$226.20$213.32
6 Apr 2023$207.54$222.89$212.89
28 Apr 2023$192.69$214.11$212.16
19 May 2023$212.78$205.09$210.20
9 Jun 2023$221.93$206.57$208.73
30 Jun 2023$250.20$212.74$209.85
21 Jul 2023$245.93$226.44$213.37
11 Aug 2023$258.39$239.89$218.48
1 Sep 2023$262.69$248.81$222.60
22 Sep 2023$250.41$254.10$225.54
13 Oct 2023$247.24$252.98$229.25
3 Nov 2023$258.11$248.09$231.33
24 Nov 2023$271.89$249.55$233.37
15 Dec 2023$279.03$255.87$236.57
5 Jan 2024$270.72$266.88$240.52
26 Jan 2024$266.51$270.27$244.11
16 Feb 2024$289.03$271.35$249.27
8 Mar 2024$334.64$283.32$257.76
28 Mar 2024$335.95$301.65$265.97
19 Apr 2024$288.23$315.50$271.61
10 May 2024$315.39$318.48$276.28
31 May 2024$324.82$313.92$280.82
21 Jun 2024$318.78$312.23$285.26
12 Jul 2024$336.03$317.86$289.67
2 Aug 2024$317.08$322.94$296.13
23 Aug 2024$324.16$322.15$302.07
13 Sep 2024$300.00$319.96$305.11
4 Oct 2024$293.54$308.67$306.69
25 Oct 2024$220.47$297.76$307.09
15 Nov 2024$189.64$267.03$303.85
6 Dec 2024$217.47$243.18$298.91
27 Dec 2024$212.29$220.23$290.58
17 Jan 2025$198.11$210.21$282.68
7 Feb 2025$193.46$207.76$275.19
28 Feb 2025$190.02$201.82$267.08
21 Mar 2025$184.87$193.83$257.00
11 Apr 2025$144.04$181.69$245.43
2 May 2025$142.96$168.25$232.79
23 May 2025$127.99$152.00$218.40
13 Jun 2025$145.66$140.02$205.69
3 Jul 2025$150.10$140.14$195.25
25 Jul 2025$187.01$144.03$184.94
15 Aug 2025$175.84$155.75$176.51
5 Sep 2025$174.88$164.80$173.56
26 Sep 2025$163.79$171.69$170.79
17 Oct 2025$185.06$176.79$168.97
7 Nov 2025$159.14$177.04$166.32
28 Nov 2025$185.00$174.43$164.18
19 Dec 2025$173.77$175.80$163.59
9 Jan 2026$181.38$176.36$163.87
30 Jan 2026$180.25$182.19$165.52
20 Feb 2026$99.70$168.98$164.42
13 Mar 2026$98.33$145.99$162.37
2 Apr 2026$114.19$122.47$159.88
24 Apr 2026$102.17$105.05$157.18
15 May 2026$116.38$109.72$153.74
5 Jun 2026$149.45$117.38$150.99
26 Jun 2026$169.86$128.87$149.18
17 Jul 2026$170.00$144.97$149.17
7 Aug 2026$164.51$159.43$147.60
28 Aug 2026$170.02$166.68$147.38
18 Sep 2026$164.11$167.27$147.27
9 Oct 2026$164.17$166.60$146.09
30 Oct 2026$211.36$171.97$145.80
4 Nov 2026$203.11$173.91$146.16
Weekly closing price ($) with its 50-day and 200-day averages. The strip under the chart shows the phase: tan sideways, green rising, yellow stalling near a high, orange falling. 10-year window.

Price stage: Falling from Oct 2025 to Nov 2025; Sideways from Nov 2025 to Jan 2026; Falling from Feb 2026 to Jun 2026; Sideways from Jun 2026 to Nov 2026.

Price stage: Rising from Nov 2023 to Aug 2024; Sideways from Sep 2024 to Jan 2025; Falling from Jan 2025 to Aug 2025; Sideways from Aug 2025 to Jan 2026; Falling from Feb 2026 to Jun 2026; Sideways from Jun 2026 to Nov 2026.

Price stage: Rising from Oct 2021 to Feb 2022; Sideways from Feb 2022 to Aug 2022; Falling from Aug 2022 to Jan 2023; Sideways from Jan 2023 to Mar 2023; Falling from Apr 2023 to May 2023; Sideways from Jun 2023 to Jul 2023; Rising from Aug 2023 to Aug 2024; Sideways from Sep 2024 to Jan 2025; Falling from Jan 2025 to Nov 2025; Sideways from Nov 2025 to Jan 2026; Falling from Feb 2026 to Jun 2026; Sideways from Jul 2026 to Nov 2026.

Price stage: Rising from Dec 2017 to Nov 2018; Sideways from Dec 2018 to Apr 2019; Rising from May 2019 to Feb 2020; Sideways from Mar 2020 to May 2020; Rising from May 2020 to Feb 2022; Sideways from Mar 2022 to Jul 2022; Falling from Aug 2022 to Dec 2022; Sideways from Jan 2023 to Feb 2023; Falling from Mar 2023 to Apr 2023; Sideways from May 2023 to Jul 2023; Rising from Aug 2023 to Aug 2024; Sideways from Sep 2024 to Jan 2025; Falling from Feb 2025 to Nov 2025; Sideways from Nov 2025 to Jan 2026; Falling from Feb 2026 to Jun 2026; Sideways from Jun 2026 to Nov 2026.

Week by week since 2016: did it beat the S&P 500 over the past 13 weeks?

Ahead in 283 of 527 weeks

Week by week since 2016: did it beat the S&P 500 over the past 13 weeks?
Week13-week return vs S&P 500
8 Jul 2016no S&P 500 reading
15 Jul 2016no S&P 500 reading
22 Jul 2016no S&P 500 reading
29 Jul 2016no S&P 500 reading
5 Aug 2016no S&P 500 reading
12 Aug 2016no S&P 500 reading
19 Aug 2016no S&P 500 reading
26 Aug 2016no S&P 500 reading
2 Sep 2016no S&P 500 reading
9 Sep 2016no S&P 500 reading
16 Sep 2016no S&P 500 reading
23 Sep 2016no S&P 500 reading
30 Sep 2016no S&P 500 reading
7 Oct 2016+7.4%
14 Oct 2016+8.8%
21 Oct 2016+18.7%
28 Oct 2016+5.5%
4 Nov 2016+4.4%
11 Nov 2016+5.6%
18 Nov 2016+0.8%
25 Nov 2016−0.4%
2 Dec 2016−3.0%
9 Dec 2016−4.5%
16 Dec 2016−6.4%
23 Dec 2016−5.8%
30 Dec 2016−6.1%
6 Jan 2017−6.1%
13 Jan 2017+0.0%
20 Jan 2017−11.3%
27 Jan 2017−5.7%
3 Feb 2017+1.6%
10 Feb 2017+0.8%
17 Feb 2017+4.8%
24 Feb 2017+2.9%
3 Mar 2017+2.4%
10 Mar 2017+0.6%
17 Mar 2017+1.0%
24 Mar 2017+1.0%
31 Mar 2017+0.5%
7 Apr 2017−1.6%
13 Apr 2017−7.9%
21 Apr 2017−3.7%
28 Apr 2017−0.9%
5 May 2017−3.7%
12 May 2017−1.8%
19 May 2017+3.7%
26 May 2017+7.1%
2 Jun 2017+13.5%
9 Jun 2017+17.8%
16 Jun 2017+14.2%
23 Jun 2017+18.1%
30 Jun 2017+20.1%
7 Jul 2017+19.6%
14 Jul 2017+22.4%
21 Jul 2017+19.8%
28 Jul 2017+18.0%
4 Aug 2017+17.7%
11 Aug 2017+13.5%
18 Aug 2017+14.8%
25 Aug 2017+16.8%
1 Sep 2017+16.2%
8 Sep 2017+17.4%
15 Sep 2017+17.0%
22 Sep 2017+12.6%
29 Sep 2017+12.6%
6 Oct 2017+10.6%
13 Oct 2017+10.6%
20 Oct 2017+9.7%
27 Oct 2017+13.4%
3 Nov 2017+13.9%
10 Nov 2017+6.5%
17 Nov 2017+5.4%
24 Nov 2017+1.7%
1 Dec 2017−4.4%
8 Dec 2017−10.4%
15 Dec 2017−4.6%
22 Dec 2017−4.9%
29 Dec 2017−7.7%
5 Jan 2018−4.0%
12 Jan 2018−9.3%
19 Jan 2018−8.8%
26 Jan 2018−15.8%
2 Feb 2018−19.7%
9 Feb 2018−7.3%
16 Feb 2018−7.8%
23 Feb 2018−7.4%
2 Mar 2018−3.0%
9 Mar 2018+4.2%
16 Mar 2018+4.3%
23 Mar 2018+7.0%
29 Mar 2018+6.7%
6 Apr 2018−0.3%
13 Apr 2018+10.4%
20 Apr 2018+8.1%
27 Apr 2018+9.5%
4 May 2018+17.5%
11 May 2018+13.6%
18 May 2018+10.0%
25 May 2018+9.1%
1 Jun 2018+12.2%
8 Jun 2018+9.7%
15 Jun 2018+9.8%
22 Jun 2018+10.1%
29 Jun 2018+9.1%
6 Jul 2018+13.1%
13 Jul 2018+10.0%
20 Jul 2018+14.2%
27 Jul 2018+13.4%
3 Aug 2018+11.4%
10 Aug 2018+13.2%
17 Aug 2018+9.2%
24 Aug 2018+10.7%
31 Aug 2018+7.6%
7 Sep 2018+4.2%
14 Sep 2018+4.1%
21 Sep 2018+3.4%
28 Sep 2018+8.8%
5 Oct 2018+7.8%
12 Oct 2018+6.1%
19 Oct 2018+2.7%
26 Oct 2018+3.9%
2 Nov 2018−0.5%
9 Nov 2018−4.3%
16 Nov 2018−3.5%
23 Nov 2018+1.1%
30 Nov 2018+2.2%
7 Dec 2018+5.3%
14 Dec 2018+0.8%
21 Dec 2018−1.3%
28 Dec 2018−2.5%
4 Jan 2019−4.8%
11 Jan 2019−0.5%
18 Jan 2019−2.8%
25 Jan 2019−2.2%
1 Feb 2019+3.7%
8 Feb 2019+3.3%
15 Feb 2019+7.8%
22 Feb 2019+2.5%
1 Mar 2019−4.7%
8 Mar 2019−12.3%
15 Mar 2019−7.1%
22 Mar 2019−7.0%
29 Mar 2019−6.6%
5 Apr 2019−1.7%
12 Apr 2019−10.7%
18 Apr 2019−10.5%
26 Apr 2019−9.1%
3 May 2019−8.0%
10 May 2019−6.3%
17 May 2019−8.3%
24 May 2019−4.3%
31 May 2019+2.7%
7 Jun 2019+8.1%
14 Jun 2019+3.3%
21 Jun 2019+5.8%
28 Jun 2019+9.0%
5 Jul 2019+7.4%
12 Jul 2019+5.1%
19 Jul 2019+14.1%
26 Jul 2019+14.3%
2 Aug 2019+8.7%
9 Aug 2019+10.6%
16 Aug 2019+13.3%
23 Aug 2019+8.1%
30 Aug 2019+2.7%
6 Sep 2019+3.8%
13 Sep 2019+0.8%
20 Sep 2019+3.3%
27 Sep 2019−5.2%
4 Oct 2019−2.8%
11 Oct 2019−3.1%
18 Oct 2019−7.2%
25 Oct 2019−7.4%
1 Nov 2019−7.3%
8 Nov 2019−12.5%
15 Nov 2019−9.6%
22 Nov 2019−7.3%
29 Nov 2019−1.7%
6 Dec 2019−0.9%
13 Dec 2019+0.9%
20 Dec 2019+3.2%
27 Dec 2019+7.4%
3 Jan 2020+4.1%
10 Jan 2020+8.4%
17 Jan 2020+12.4%
24 Jan 2020+8.5%
31 Jan 2020+7.1%
7 Feb 2020+8.2%
14 Feb 2020+5.1%
21 Feb 2020+2.2%
28 Feb 2020+1.4%
6 Mar 2020+3.6%
13 Mar 2020+10.0%
20 Mar 2020−0.6%
27 Mar 2020+0.1%
3 Apr 2020+0.9%
9 Apr 2020+5.8%
17 Apr 2020+4.6%
24 Apr 2020−0.9%
1 May 2020+3.5%
8 May 2020+6.0%
15 May 2020+4.8%
22 May 2020+8.8%
29 May 2020+5.2%
5 Jun 2020−5.5%
12 Jun 2020−8.3%
19 Jun 2020−1.6%
26 Jun 2020−0.1%
2 Jul 2020+1.7%
10 Jul 2020−3.4%
17 Jul 2020+5.8%
24 Jul 2020+10.8%
31 Jul 2020+4.8%
7 Aug 2020+5.1%
14 Aug 2020+2.0%
21 Aug 2020−2.7%
28 Aug 2020−6.7%
4 Sep 2020+2.2%
11 Sep 2020+6.9%
18 Sep 2020+2.5%
25 Sep 2020+5.1%
2 Oct 2020+10.9%
9 Oct 2020+15.5%
16 Oct 2020+0.1%
23 Oct 2020−2.7%
30 Oct 2020−2.8%
6 Nov 2020+0.3%
13 Nov 2020−4.7%
20 Nov 2020−3.1%
27 Nov 2020+0.9%
4 Dec 2020+4.7%
11 Dec 2020−4.9%
18 Dec 2020−2.0%
24 Dec 2020−7.1%
31 Dec 2020−12.8%
8 Jan 2021−8.6%
15 Jan 2021−5.0%
22 Jan 2021+0.5%
29 Jan 2021−0.3%
5 Feb 2021−10.3%
12 Feb 2021+0.6%
19 Feb 2021+0.0%
26 Feb 2021−10.1%
5 Mar 2021−14.0%
12 Mar 2021−13.3%
19 Mar 2021−9.7%
26 Mar 2021−8.2%
1 Apr 2021−3.4%
9 Apr 2021−15.7%
16 Apr 2021−13.9%
23 Apr 2021−8.1%
30 Apr 2021−6.3%
7 May 2021+5.4%
14 May 2021+2.8%
21 May 2021+4.6%
28 May 2021+13.4%
4 Jun 2021+12.4%
11 Jun 2021+10.9%
18 Jun 2021+7.5%
25 Jun 2021+6.1%
2 Jul 2021−2.0%
9 Jul 2021+0.4%
16 Jul 2021+2.9%
23 Jul 2021−5.5%
30 Jul 2021+7.0%
6 Aug 2021+0.8%
13 Aug 2021−2.7%
20 Aug 2021+0.4%
27 Aug 2021+6.2%
3 Sep 2021+11.8%
10 Sep 2021+14.7%
17 Sep 2021+20.0%
24 Sep 2021+26.3%
1 Oct 2021+21.8%
8 Oct 2021+25.5%
15 Oct 2021+23.2%
22 Oct 2021+24.3%
29 Oct 2021+13.2%
5 Nov 2021+4.1%
12 Nov 2021+14.7%
19 Nov 2021+9.7%
26 Nov 2021+5.3%
3 Dec 2021+3.9%
10 Dec 2021+1.4%
17 Dec 2021+3.1%
23 Dec 2021+2.8%
31 Dec 2021+8.7%
7 Jan 2022−0.6%
14 Jan 2022−7.4%
21 Jan 2022−5.9%
28 Jan 2022−4.5%
4 Feb 2022+4.6%
11 Feb 2022−2.7%
18 Feb 2022−13.3%
25 Feb 2022−7.8%
4 Mar 2022−12.4%
11 Mar 2022−8.4%
18 Mar 2022−13.4%
25 Mar 2022−18.7%
1 Apr 2022−15.7%
8 Apr 2022−2.9%
14 Apr 2022−1.8%
22 Apr 2022−4.4%
29 Apr 2022−7.2%
6 May 2022−7.7%
13 May 2022−10.5%
20 May 2022+5.5%
27 May 2022+0.6%
3 Jun 2022+3.2%
10 Jun 2022+5.1%
17 Jun 2022+1.6%
24 Jun 2022+6.3%
1 Jul 2022+2.1%
8 Jul 2022−3.4%
15 Jul 2022−2.2%
22 Jul 2022+1.8%
29 Jul 2022+6.7%
5 Aug 2022+3.4%
12 Aug 2022+8.0%
19 Aug 2022−0.2%
26 Aug 2022−3.7%
2 Sep 2022−2.6%
9 Sep 2022−1.1%
16 Sep 2022−3.6%
23 Sep 2022−7.8%
30 Sep 2022−7.3%
7 Oct 2022−7.8%
14 Oct 2022−10.5%
21 Oct 2022−14.2%
28 Oct 2022−11.8%
4 Nov 2022−5.4%
11 Nov 2022−1.5%
18 Nov 2022−1.1%
25 Nov 2022+3.3%
2 Dec 2022−0.7%
9 Dec 2022−10.6%
16 Dec 2022−8.0%
23 Dec 2022−2.0%
30 Dec 2022−1.4%
6 Jan 2023+0.5%
13 Jan 2023+17.7%
20 Jan 2023+24.3%
27 Jan 2023+10.3%
3 Feb 2023+12.6%
10 Feb 2023+2.5%
17 Feb 2023+2.2%
24 Feb 2023+3.5%
3 Mar 2023+10.4%
10 Mar 2023+11.7%
17 Mar 2023+9.4%
24 Mar 2023+2.7%
31 Mar 2023+2.9%
6 Apr 2023−1.9%
14 Apr 2023−10.1%
21 Apr 2023−14.6%
28 Apr 2023−18.1%
5 May 2023−22.3%
12 May 2023−14.8%
19 May 2023−9.3%
26 May 2023−14.8%
2 Jun 2023−11.2%
9 Jun 2023−7.6%
16 Jun 2023+0.0%
23 Jun 2023+0.0%
30 Jun 2023+8.9%
7 Jul 2023+6.7%
14 Jul 2023+8.5%
21 Jul 2023+9.0%
28 Jul 2023+21.0%
4 Aug 2023+25.2%
11 Aug 2023+20.9%
18 Aug 2023+13.4%
25 Aug 2023+21.1%
1 Sep 2023+13.2%
8 Sep 2023+9.1%
15 Sep 2023+10.9%
22 Sep 2023+11.3%
29 Sep 2023+2.0%
6 Oct 2023+3.5%
13 Oct 2023+4.4%
20 Oct 2023−1.0%
27 Oct 2023+3.4%
3 Nov 2023+4.6%
10 Nov 2023+0.3%
17 Nov 2023+4.6%
24 Nov 2023+2.6%
1 Dec 2023+0.8%
8 Dec 2023+5.6%
15 Dec 2023+0.8%
22 Dec 2023+2.0%
29 Dec 2023+3.8%
5 Jan 2024+4.0%
12 Jan 2024−7.3%
19 Jan 2024−0.1%
26 Jan 2024−5.4%
2 Feb 2024−12.8%
9 Feb 2024−5.1%
16 Feb 2024−3.7%
23 Feb 2024+4.0%
1 Mar 2024+9.1%
8 Mar 2024+11.6%
15 Mar 2024+11.3%
22 Mar 2024+8.3%
28 Mar 2024+8.6%
5 Apr 2024+7.0%
12 Apr 2024+12.8%
19 Apr 2024+8.4%
26 Apr 2024+11.4%
3 May 2024+15.2%
10 May 2024+9.3%
17 May 2024+2.9%
24 May 2024−2.2%
31 May 2024−3.0%
7 Jun 2024−8.9%
14 Jun 2024−12.9%
21 Jun 2024−8.5%
28 Jun 2024−10.7%
5 Jul 2024−6.4%
12 Jul 2024+0.2%
19 Jul 2024+3.5%
26 Jul 2024−2.2%
2 Aug 2024−1.6%
9 Aug 2024−3.1%
16 Aug 2024−2.2%
23 Aug 2024−5.1%
30 Aug 2024−7.7%
6 Sep 2024−6.4%
13 Sep 2024−7.8%
20 Sep 2024−9.3%
27 Sep 2024−13.9%
4 Oct 2024−11.8%
11 Oct 2024−15.2%
18 Oct 2024−16.2%
25 Oct 2024−38.2%
1 Nov 2024−37.6%
8 Nov 2024−43.5%
15 Nov 2024−46.9%
22 Nov 2024−39.8%
29 Nov 2024−41.6%
6 Dec 2024−40.6%
13 Dec 2024−38.1%
20 Dec 2024−35.6%
27 Dec 2024−29.8%
3 Jan 2025−30.7%
10 Jan 2025−26.6%
17 Jan 2025−35.7%
24 Jan 2025−14.1%
31 Jan 2025−15.1%
7 Feb 2025−10.4%
14 Feb 2025−5.9%
21 Feb 2025−6.7%
28 Feb 2025−8.2%
7 Mar 2025−9.0%
14 Mar 2025−4.5%
21 Mar 2025−6.3%
28 Mar 2025−9.0%
4 Apr 2025−13.3%
11 Apr 2025−26.0%
17 Apr 2025−17.8%
25 Apr 2025−18.3%
2 May 2025−22.4%
9 May 2025−24.7%
16 May 2025−26.8%
23 May 2025−33.0%
30 May 2025−30.6%
6 Jun 2025−29.5%
13 Jun 2025−27.2%
20 Jun 2025−26.1%
27 Jun 2025−29.9%
3 Jul 2025−26.1%
11 Jul 2025−12.3%
18 Jul 2025−16.2%
25 Jul 2025+13.3%
1 Aug 2025+6.7%
8 Aug 2025+5.4%
15 Aug 2025+25.3%
22 Aug 2025+25.9%
29 Aug 2025+27.1%
5 Sep 2025+17.7%
12 Sep 2025+10.0%
19 Sep 2025+7.1%
26 Sep 2025+5.7%
3 Oct 2025+22.2%
10 Oct 2025+17.2%
17 Oct 2025+23.1%
24 Oct 2025−11.1%
31 Oct 2025−6.5%
7 Nov 2025−4.9%
14 Nov 2025−12.2%
21 Nov 2025−8.5%
28 Nov 2025−2.0%
5 Dec 2025+0.3%
12 Dec 2025+2.9%
19 Dec 2025−2.7%
26 Dec 2025+7.3%
2 Jan 2026−4.8%
9 Jan 2026−7.4%
16 Jan 2026−5.4%
23 Jan 2026+3.1%
30 Jan 2026+3.5%
6 Feb 2026−8.3%
13 Feb 2026−44.1%
20 Feb 2026−44.0%
27 Feb 2026−41.9%
6 Mar 2026−40.4%
13 Mar 2026−44.4%
20 Mar 2026−37.9%
27 Mar 2026−36.0%
2 Apr 2026−35.5%
10 Apr 2026−39.0%
17 Apr 2026−37.1%
24 Apr 2026−48.9%
1 May 2026−41.5%
8 May 2026−24.1%
15 May 2026+16.7%
22 May 2026+9.0%
29 May 2026+15.6%
5 Jun 2026+29.7%
12 Jun 2026+36.7%
18 Jun 2026+31.3%
26 Jun 2026+51.4%
2 Jul 2026+38.0%
10 Jul 2026+45.9%
17 Jul 2026+37.4%
24 Jul 2026+58.7%
31 Jul 2026+41.3%
7 Aug 2026+27.3%
14 Aug 2026+35.2%
21 Aug 2026+44.8%
28 Aug 2026+23.2%
4 Sep 2026+5.9%
11 Sep 2026+12.8%
18 Sep 2026+10.4%
25 Sep 2026−4.4%
2 Oct 2026−9.7%
9 Oct 2026−5.2%
16 Oct 2026−2.6%
23 Oct 2026+8.9%
30 Oct 2026+28.1%
4 Nov 2026+24.3%
Each bar is one week, from 2016 to now (527 weeks with a reading). Green means the stock's return over the previous 13 weeks beat the S&P 500; red means it trailed. The colour is strongest at a gap of 25 percentage points or more. A gap means there is no reading for that week.

Over the last 10 years the share price moved +179% while the S&P 500 moved +261%, so it is behind the index over that whole period. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

What dividend does ICON Public Limited pay?

ICON Public Limited Company pays no dividend. In the last 12 reported quarters it declared no dividend per share, so there is no payout history to chart and no yield to show. Companies like this usually keep their earnings in the business, so the cash-flow sections show where that cash goes.

Which stock lists is ICON Public Limited on?

ICON Public Limited is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list.

Is ICON Public Limited profitable?

ICON Public Limited Company earned $72.6 M of net profit in the Jun 2026 quarter, −64.3% on the same quarter a year earlier. Full-year FY25 profit was $214 M. Over 4 years profit has grown 8.7% a year on average. That is 3.5% of the quarter's revenue. The same quarter a year earlier earned $204 M.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

1 of the last 12 reported quarters were loss-making.

For the full year, FY25 profit was $214 M (−70.6% on the year before).

FY25 profit $214 M (−70.6% on the year before), 8.7% a year over 4 years

  • Net profit $214 M
FY25 profit $214 M (−70.6% on the year before), 8.7% a year over 4 years
QuarterNet profit
FY21$153 M
FY22$505 M
FY23$554 M
FY24$727 M
FY25$214 M

Growth on a year earlier

  • Growth on a year earlier −70.6%
Growth on a year earlier
QuarterGrowth on a year earlier
FY21–
FY22229.9%
FY239.7%
FY2431.2%
FY25−70.6%
Top: net profit each year, $ M. Below: growth on the year before, %. 5-year window. A grey bar is lower than the year before.

Jun 2026: $72.6 M (−64.3% on a year earlier)

  • Net profit (quarterly) $72.6 M
Jun 2026: $72.6 M (−64.3% on a year earlier)
QuarterNet profit (quarterly)
Sep 2023$164 M
Dec 2023$216 M
Mar 2024$187 M
Jun 2024$147 M
Sep 2024$197 M
Dec 2024$196 M
Mar 2025$161 M
Jun 2025$204 M
Sep 2025$2.4 M
Dec 2025−$125 M
Mar 2026$105 M
Jun 2026$72.6 M

Growth on a year earlier

  • Growth on a year earlier −64.3%
Growth on a year earlier
QuarterGrowth on a year earlier
Sep 20232.2%
Dec 202384.3%
Mar 202460.7%
Jun 202427.1%
Sep 202420.4%
Dec 2024−9.6%
Mar 2025−14.2%
Jun 202538.5%
Sep 2025−98.8%
Dec 2025−164.1%
Mar 2026−34.9%
Jun 2026−64.3%
Top: net profit each quarter, $ M. Below: growth on the same quarter a year earlier, %. Last 12 quarters. A grey bar is lower than the quarter before.

Why profit moved: revenue changed +1.2% on a year earlier and the margin moved −4.4 percentage points. Sales did the work while the margin got thinner.

On average over the last four quarters, profit changed −90.5% and revenue +3.8%. Profit is growing slower than sales: rising costs are taking part of the growth.

How much revenue does ICON Public Limited make, and is it growing?

ICON Public Limited Company reported $2.1 B of revenue in the Jun 2026 quarter, +1.2% on the same quarter a year earlier. That is the 4th quarter in a row with growth on the year before. Over 4 years it has grown 10.8% a year on average. The last full year, FY25, came in at $8.3 B.

Revenue is everything the company billed its customers in the period.

The last four reported quarters add to $8.3 B.

FY25 revenue was $8.3 B, +0.8% on the year before.

FY25 revenue $8.3 B (+0.8% on the year before), 10.8% a year over 4 years

  • Revenue $8.3 B
FY25 revenue $8.3 B (+0.8% on the year before), 10.8% a year over 4 years
QuarterRevenue
FY21$5.5 B
FY22$7.7 B
FY23$8.1 B
FY24$8.2 B
FY25$8.3 B

Growth on a year earlier

  • Growth on a year earlier 0.8%
Growth on a year earlier
QuarterGrowth on a year earlier
FY21–
FY2241.2%
FY234.1%
FY241.7%
FY250.8%
Top: revenue each year, $ B. Below: growth on the year before, %. 5-year window. A grey bar is lower than the year before.

Jun 2026: $2.1 B (+1.2% on a year earlier), the 4th quarter in a row of growth

  • Revenue (quarterly) $2.1 B
Jun 2026: $2.1 B (+1.2% on a year earlier), the 4th quarter in a row of growth
QuarterRevenue (quarterly)
Sep 2023$2.1 B
Dec 2023$2.1 B
Mar 2024$2.1 B
Jun 2024$2.1 B
Sep 2024$2.0 B
Dec 2024$1.9 B
Mar 2025$2.0 B
Jun 2025$2.0 B
Sep 2025$2.0 B
Dec 2025$2.2 B
Mar 2026$2.0 B
Jun 2026$2.1 B

Growth on a year earlier

  • Growth on a year earlier 1.2%
Growth on a year earlier
QuarterGrowth on a year earlier
Sep 20235.8%
Dec 20235.3%
Mar 20245.7%
Jun 20244.9%
Sep 2024−1.2%
Dec 2024−5.7%
Mar 2025−3.6%
Jun 2025−3.8%
Sep 20250.6%
Dec 202512.4%
Mar 20260.9%
Jun 20261.2%
Top: revenue each quarter, $ B. Below: growth on the same quarter a year earlier, %. Last 12 quarters. A grey bar is lower than the quarter before.

Recent pace: the last four quarters grew +3.8% on average, against 10.8% a year over the longer run, so this year is growing slower than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +3.7%, against +0.0% a year over the last 8 quarters (accelerating); profit over the last 12 months grew −92.8%, against −72.4% a year (rolling over).

How much of every $100 of sales does ICON Public Limited keep?

ICON Public Limited Company's operating margin was 9.4% in the Jun 2026 quarter, 4.4 percentage points lower than the same quarter a year ago. Across 5 years it has been between 5.2% and 12.7%. The latest quarter is within that range.

Operating margin is what is left from every $100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why the margin moved: operating margin changed −4.4 percentage points on the year while gross margin changed −5.4 points. So the drop came mostly from the gross margin, which means input costs and prices charged.

FY25: 5.2%, within a range of 5.2% to 12.7% over 5 years

  • Operating margin 5.2%
FY25: 5.2%, within a range of 5.2% to 12.7% over 5 years
QuarterOperating margin
FY219.7%
FY2211.2%
FY2312.3%
FY2412.7%
FY255.2%

Change on the year before (points)

  • Change on the year before (points) −7.5 pts
Change on the year before (points)
QuarterChange on the year before (points)
FY21–
FY22+1.5 pts
FY23+1.1 pts
FY24+0.4 pts
FY25−7.5 pts
Operating margin each year, % (top). Below: change on the year before, in percentage points. 5-year window.

Jun 2026: operating margin 9.4% (−4.4 points on a year earlier)

  • Operating margin 9.4%
Jun 2026: operating margin 9.4% (−4.4 points on a year earlier)
QuarterOperating margin
Sep 202313.4%
Dec 202313.3%
Mar 202414%
Jun 202413.3%
Sep 202414.4%
Dec 20248.6%
Mar 202513.5%
Jun 202513.8%
Sep 202512.7%
Dec 2025−16.2%
Mar 20269.2%
Jun 20269.4%

Change on a year earlier (points)

  • Change on a year earlier (points) −4.4 pts
Change on a year earlier (points)
QuarterChange on a year earlier (points)
Sep 2023+0.1 pts
Dec 2023+2.5 pts
Mar 2024+2.0 pts
Jun 2024+0.5 pts
Sep 2024+1.0 pts
Dec 2024−4.7 pts
Mar 2025−0.5 pts
Jun 2025+0.5 pts
Sep 2025−1.7 pts
Dec 2025−24.8 pts
Mar 2026−4.3 pts
Jun 2026−4.4 pts
Top: quarterly operating margin, %. Below: change on the same quarter a year earlier, in percentage points. Last 12 quarters. Operating profit as a share of revenue, each quarter.

Is ICON Public Limited's profit turning into cash?

Over the last 3 years, 239% of ICON Public Limited Company's reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in $1.1 B of operating cash against $214 M of profit. After $69.8 M of spending on assets, $1.0 B was left over as free cash.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

FY25: operating cash $1.1 B against profit $214 M; 239% of 3 years' profit came in as cash

  • Operating cash $1.1 B
  • Net profit $214 M
  • Free cash $1.0 B
FY25: operating cash $1.1 B against profit $214 M; 239% of 3 years' profit came in as cash
QuarterOperating cashNet profitFree cash
FY21$829 M$153 M$735 M
FY22$563 M$505 M$421 M
FY23$1.2 B$554 M$1.0 B
FY24$1.3 B$727 M$1.3 B
FY25$1.1 B$214 M$1.0 B
Operating cash flow and net profit each year, $ B. The line is free cash flow: operating cash minus spending on assets. 5-year window, yearly figures.

Jun 2026: operating cash $281 M = 388% of the quarter's profit

  • Operating cash (quarterly) $281 M
Jun 2026: operating cash $281 M = 388% of the quarter's profit
QuarterOperating cash (quarterly)
Sep 2023$342 M
Dec 2023$440 M
Mar 2024$327 M
Jun 2024$219 M
Sep 2024$403 M
Dec 2024$386 M
Mar 2025$268 M
Jun 2025$146 M
Sep 2025$388 M
Dec 2025$276 M
Mar 2026$167 M
Jun 2026$281 M

Operating cash as % of profit

  • Operating cash as % of profit 388%
Operating cash as % of profit
QuarterOperating cash as % of profit
Sep 2023209%
Dec 2023203%
Mar 2024174%
Jun 2024149%
Sep 2024204%
Dec 2024197%
Mar 2025167%
Jun 202572%
Sep 202516,459%
Dec 2025–
Mar 2026159%
Jun 2026388%
Top: operating cash each quarter, $ M. Below: operating cash as a % of net profit; 100% means all of the quarter's profit came in as cash. Last 12 quarters.

Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason.

What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building.

Where does ICON Public Limited's cash go?

ICON Public Limited Company does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $267 M on assets over the last 3 years. Averaged over those years that is 1.1% of FY25 revenue a year.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn.

Spending on assets: $267 M over the last 3 years.

FY25: capex $69.8 M, steady spending

  • Capex $69.8 M
FY25: capex $69.8 M, steady spending
QuarterCapex
FY21$93.8 M
FY22$142 M
FY23$141 M
FY24$56.8 M
FY25$69.8 M
Capital spending each year, $ M.

Jun 2026: capex $42.4 M in the quarter

  • Capex (quarterly) $42.4 M
Jun 2026: capex $42.4 M in the quarter
QuarterCapex (quarterly)
Sep 2023$29.1 M
Dec 2023$52.7 M
Mar 2024$27.2 M
Jun 2024$36.3 M
Sep 2024$43.3 M
Dec 2024$50.0 M
Mar 2025$28.9 M
Jun 2025$32.3 M
Sep 2025$53.7 M
Dec 2025$45.1 M
Mar 2026$30.8 M
Jun 2026$42.4 M

Free cash

  • Free cash $239 M
Free cash
QuarterFree cash
Sep 2023$312 M
Dec 2023$387 M
Mar 2024$300 M
Jun 2024$182 M
Sep 2024$359 M
Dec 2024$436 M
Mar 2025$239 M
Jun 2025$114 M
Sep 2025$334 M
Dec 2025$321 M
Mar 2026$136 M
Jun 2026$239 M
Top: capital spending each quarter, $ M. Below: free cash flow, $ M. Last 12 quarters.

In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns.

What is ICON Public Limited's P/E ratio, and how does it compare with its own history?

ICON Public Limited Company's P/E is 36.3×, with too little history to compare. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many dollars the market pays for each dollar of yearly profit.

P/E 36.3× against a usual —: with too little history to compare

  • P/E 249.4×
P/E 36.3× against a usual —: with too little history to compare
WeekP/E
1 Apr 202299.0×
14 Apr 202298.8×
29 Apr 202290.8×
13 May 202284.7×
27 May 202291.3×
10 Jun 202288.0×
24 Jun 202288.6×
8 Jul 202286.5×
22 Jul 202287.7×
5 Aug 202292.5×
19 Aug 202292.7×
2 Sep 202282.0×
16 Sep 202281.2×
30 Sep 202232.6×
14 Oct 202230.9×
28 Oct 202235.4×
11 Nov 202239.3×
25 Nov 202238.9×
9 Dec 202234.6×
23 Dec 202234.6×
6 Jan 202332.6×
20 Jan 202337.7×
3 Feb 202339.7×
17 Feb 202337.1×
3 Mar 202338.1×
17 Mar 202333.8×
31 Mar 202334.5×
14 Apr 202333.9×
28 Apr 202331.1×
12 May 202332.3×
26 May 202332.9×
9 Jun 202335.9×
23 Jun 202336.6×
7 Jul 202338.3×
21 Jul 202339.8×
4 Aug 202341.0×
18 Aug 202340.5×
1 Sep 202342.5×
15 Sep 202342.4×
29 Sep 202339.9×
13 Oct 202339.8×
27 Oct 202337.9×
10 Nov 202341.3×
24 Nov 202343.8×
8 Dec 202343.9×
22 Dec 202345.2×
5 Jan 202436.7×
19 Jan 202435.2×
2 Feb 202435.3×
16 Feb 202439.2×
1 Mar 202444.1×
15 Mar 202445.4×
28 Mar 202445.5×
12 Apr 202437.2×
26 Apr 202437.5×
10 May 202438.4×
24 May 202439.0×
7 Jun 202438.9×
21 Jun 202438.8×
5 Jul 202437.4×
19 Jul 202438.4×
2 Aug 202437.0×
16 Aug 202437.6×
30 Aug 202437.5×
13 Sep 202435.0×
27 Sep 202433.3×
11 Oct 202433.1×
25 Oct 202424.6×
8 Nov 202424.0×
22 Nov 202423.9×
6 Dec 202424.3×
20 Dec 202423.1×
3 Jan 202524.4×
17 Jan 202522.7×
31 Jan 202522.8×
14 Feb 202521.3×
28 Feb 202521.7×
14 Mar 202521.1×
28 Mar 202520.5×
11 Apr 202517.0×
25 Apr 202517.1×
9 May 202515.8×
23 May 202515.1×
6 Jun 202516.4×
20 Jun 202517.3×
3 Jul 202516.2×
18 Jul 202515.5×
1 Aug 202517.9×
15 Aug 202518.9×
29 Aug 202519.2×
12 Sep 202518.9×
26 Sep 202517.6×
10 Oct 202526.4×
24 Oct 202525.6×
7 Nov 202522.9×
21 Nov 202523.7×
5 Dec 202526.7×
19 Dec 202525.0×
2 Jan 202664.2×
16 Jan 202662.1×
30 Jan 202661.3×
13 Feb 202631.6×
27 Feb 202636.8×
13 Mar 202633.4×
27 Mar 202634.7×
10 Apr 202646.2×
24 Apr 202644.2×
8 May 202653.9×
22 May 202650.5×
5 Jun 202664.7×
18 Jun 202663.2×
2 Jul 2026249.4×
17 Jul 2026246.0×
31 Jul 2026236.7×
14 Aug 2026236.1×
28 Aug 2026246.1×
11 Sep 2026245.0×
25 Sep 2026249.4×
9 Oct 2026237.6×
23 Oct 2026249.4×
4 Nov 2026249.4×

Earnings per share, 12 months

  • Earnings per share, 12 months $0.69
Earnings per share, 12 months
WeekEarnings per share, 12 months
1 Apr 2022–
14 Apr 2022–
29 Apr 2022–
13 May 2022–
27 May 2022–
10 Jun 2022–
24 Jun 2022$2.49
8 Jul 2022$2.49
22 Jul 2022$2.49
5 Aug 2022$2.49
19 Aug 2022$2.49
2 Sep 2022$2.49
16 Sep 2022$2.49
30 Sep 2022$5.63
14 Oct 2022$5.63
28 Oct 2022$5.63
11 Nov 2022$5.63
25 Nov 2022$5.63
9 Dec 2022$5.63
23 Dec 2022$5.63
6 Jan 2023$5.63
20 Jan 2023$5.63
3 Feb 2023$5.63
17 Feb 2023$5.63
3 Mar 2023$5.63
17 Mar 2023$5.63
31 Mar 2023$6.19
14 Apr 2023$6.19
28 Apr 2023$6.19
12 May 2023$6.19
26 May 2023$6.19
9 Jun 2023$6.19
23 Jun 2023$6.18
7 Jul 2023$6.18
21 Jul 2023$6.18
4 Aug 2023$6.18
18 Aug 2023$6.18
1 Sep 2023$6.18
15 Sep 2023$6.18
29 Sep 2023$6.18
13 Oct 2023$6.18
27 Oct 2023$6.18
10 Nov 2023$6.18
24 Nov 2023$6.18
8 Dec 2023$6.18
22 Dec 2023$6.18
5 Jan 2024$6.21
19 Jan 2024$6.21
2 Feb 2024$6.21
16 Feb 2024$6.21
1 Mar 2024$6.21
15 Mar 2024$6.21
28 Mar 2024$7.38
12 Apr 2024$7.38
26 Apr 2024$7.38
10 May 2024$7.38
24 May 2024$7.38
7 Jun 2024$7.38
21 Jun 2024$8.22
5 Jul 2024$8.22
19 Jul 2024$8.22
2 Aug 2024$8.22
16 Aug 2024$8.22
30 Aug 2024$8.22
13 Sep 2024$8.22
27 Sep 2024$8.58
11 Oct 2024$8.58
25 Oct 2024$8.58
8 Nov 2024$8.58
22 Nov 2024$8.58
6 Dec 2024$8.58
20 Dec 2024$8.58
3 Jan 2025$8.97
17 Jan 2025$8.97
31 Jan 2025$8.97
14 Feb 2025$8.97
28 Feb 2025$8.97
14 Mar 2025$8.97
28 Mar 2025$8.74
11 Apr 2025$8.74
25 Apr 2025$8.74
9 May 2025$8.74
23 May 2025$8.74
6 Jun 2025$8.74
20 Jun 2025$8.74
3 Jul 2025$8.48
18 Jul 2025$8.48
1 Aug 2025$8.48
15 Aug 2025$8.48
29 Aug 2025$8.48
12 Sep 2025$8.48
26 Sep 2025$9.28
10 Oct 2025$9.28
24 Oct 2025$9.28
7 Nov 2025$9.28
21 Nov 2025$9.28
5 Dec 2025$9.28
19 Dec 2025$9.28
2 Jan 2026$6.95
16 Jan 2026$6.95
30 Jan 2026$6.95
13 Feb 2026$6.95
27 Feb 2026$6.95
13 Mar 2026$6.95
27 Mar 2026$2.94
10 Apr 2026$2.94
24 Apr 2026$2.94
8 May 2026$2.94
22 May 2026$2.94
5 Jun 2026$2.94
18 Jun 2026$2.94
2 Jul 2026$2.31
17 Jul 2026$2.31
31 Jul 2026$2.31
14 Aug 2026$2.31
28 Aug 2026$2.31
11 Sep 2026$2.31
25 Sep 2026$0.69
9 Oct 2026$0.69
23 Oct 2026$0.69
4 Nov 2026$0.69
Top: P/E each week. Below: earnings per share, trailing twelve months, a step line that moves once a quarter; 4.6 years of history; short peaks above 249× are drawn at the top edge.

PEG 2.77 at the Jun 2026 quarter end: above 1.0, so the P/E is bigger than the earnings growth rate

  • PEG 2.77×
  • PEG = 1.0 1.00×
PEG 2.77 at the Jun 2026 quarter end: above 1.0, so the P/E is bigger than the earnings growth rate
QuarterPEGPEG = 1.0
Dec 20211.24×1.00×
Mar 20221.02×1.00×
Jun 20220.90×1.00×
Sep 20220.99×1.00×
Dec 20221.04×1.00×
Mar 20231.09×1.00×
Jun 20230.95×1.00×
Sep 20231.19×1.00×
Dec 20231.45×1.00×
Mar 20241.53×1.00×
Jun 20241.29×1.00×
Sep 20241.15×1.00×
Dec 20241.50×1.00×
Mar 20251.59×1.00×
Jun 20251.91×1.00×
Sep 20251.86×1.00×
Dec 20252.67×1.00×
Mar 20261.98×1.00×
Jun 20262.77×1.00×
PEG each quarter: the P/E divided by the yearly growth rate of earnings. The flat line marks 1.0. Below it the P/E is smaller than the growth rate; above it the P/E is bigger. Last 19 quarters.
36.3×P/E · too little history to compare
3.10PEG · today, as reported

Why the multiple is where it is: over the past year earnings per share moved −69.0% while the price moved +27.6%. The price did better than earnings, which pushed the multiple up within its own range.

Where the price move came from: over 3 years the price moved −7.7% a year; about −51.9% a year came from earnings growth and about +44.2 percentage points from the multiple (the market paying more). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple.

In short: there is too little history to say whether the multiple is high or low for this company, so the earnings trend underneath matters more than the multiple.

Is the ICON Public Limited business getting better or worse?

ICON Public Limited Company's business is getting worse. Profit and EPS growth are shrinking: profit growth is −92.8% in the latest quarter, against +45.7% at its best in 12 quarters, with ROCE falling at 2.2%. This is based on 12 quarters of 4 measures.

Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.

Growth year by year: revenue +0.8% in FY25, profit −70.6%

  • Revenue growth 0.8%
Growth year by year: revenue +0.8% in FY25, profit −70.6%
QuarterRevenue growth
FY21–
FY2241.2%
FY234.1%
FY241.7%
FY250.8%

Profit growth, EPS growth

  • Profit growth −70.6%
  • EPS growth −69%
Profit growth, EPS growth
QuarterProfit growthEPS growth
FY21––
FY22229.9%172.4%
FY239.7%9.3%
FY2431.2%30.6%
FY25−70.6%−69%
Growth on the year before, each year, %. Top: revenue. Below: net profit and earnings per share, on their own scale because profit growth swings much more. Zero line drawn.

Three growth lines over twelve quarters: revenue accelerating, profit rolling over

  • Revenue 3.7%
Three growth lines over twelve quarters: revenue accelerating, profit rolling over
QuarterRevenue
Sep 20234.6%
Dec 20234.9%
Mar 20245.3%
Jun 20245.4%
Sep 20243.6%
Dec 20240.8%
Mar 2025−1.4%
Jun 2025−3.6%
Sep 2025−3.1%
Dec 20251.2%
Mar 20262.4%
Jun 20263.7%

Profit, EPS

  • Profit −92.8%
  • EPS −92.6%
Profit, EPS
QuarterProfitEPS
Sep 202310.6%10.3%
Dec 202321.2%20.1%
Mar 202433.9%32.7%
Jun 202440.1%38.8%
Sep 202445.7%44.4%
Dec 202418.7%18.5%
Mar 20252.5%3.3%
Jun 20256%8.3%
Sep 2025−24.8%−22.4%
Dec 2025−66.8%−66.4%
Mar 2026−73.6%−72.8%
Jun 2026−92.8%−92.6%
Growth on a year earlier, % at each quarter end. Top: revenue. Below: profit and earnings per share, on their own scale because they swing much more. Each is measured over the last 12 months. A gap means there is no reading for that quarter.

ROCE: the return line, worked out each quarter

  • ROCE 2.2%
ROCE: the return line, worked out each quarter
QuarterROCE
Sep 20236.9%
Dec 20237.3%
Mar 20247.7%
Jun 20247.9%
Sep 20248%
Dec 20247.4%
Mar 20257.2%
Jun 20257.2%
Sep 20257.1%
Dec 20253.4%
Mar 20262.7%
Jun 20262.2%
Operating profit over the last 12 months (before interest and tax) as a share of average capital employed (total assets minus current liabilities), %.
Steady highRevenue growth · latest +3.7%, range −3.6% to +5.4%
FallingProfit growth · latest −92.8%, range −92.8% to +45.7%
FallingEPS growth · latest −92.6%, range −92.6% to +44.4%
FallingROCE · latest 2.2%, range 2.2% to 8.0%

Why it matters: falling lines mean any ratio below that looks low should be read with that direction in mind.

Compound annual growth rate (%)

Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the stock price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.

Compound annual growth rate (%)
Measure1yr3yr5yr10yr
Revenue+0.8%+2.1%——
Profit−70.6%−24.9%——
EPS−69.0%−23.8%——
Stock price+27.6%−7.7%−5.2%+10.3%
+1.2%Revenue growth (Jun 2026) · latest quarter against a year ago
−64.3%Profit growth (Jun 2026) · latest quarter against a year ago
10.8%Revenue, 4 years · yearly growth over the long run

How much does ICON Public Limited earn on its capital?

ICON Public Limited Company earned a ROE of 2% in FY25. Its return on capital used (ROIC) is 8.1 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a 2.6% net margin and 0.51× asset turnover (sales divided by assets).

Return on equity (ROE) is the profit the business earns on its shareholders’ money. We do not have the full capital split, so ROE is the longest history we can draw here.

Why the return is what it is (FY25): a 2.6% net margin × 0.51× asset turnover × 1.77× leverage (assets divided by equity) ≈ 2.3% on equity. The margin does its share; borrowing is a big part of it.

The key test, return on capital used minus the cost of capital: 1.6% − 9.7% = −8.1 percentage points. The 9.7% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve.

The 1.6% ROIC above is the latest reading, as reported. The yearly chart below shows FY25 at 3.2%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method.

FY25: ROE 2%, the full history

  • ROE 2.3%
  • ROIC (annual) 3.2%
  • Cost of capital 9.7%
FY25: ROE 2%, the full history
QuarterROEROIC (annual)Cost of capital
FY211.9%5.8%9.7%
FY225.9%6%9.7%
FY236%7.5%9.7%
FY247.7%7.4%9.7%
FY252.3%3.2%9.7%
Return on equity each year, % (line); ROIC each year, % (line). 5-year window, low years included. The flat line is the 9.7% cost of capital used on this page.

Jun 2026: ROIC 1.3% (last 12 months) against a 9.7% cost of capital

  • ROIC (12 months) 1.3%
  • ROE (12 months) 4.5%
  • Cost of capital 9.7%
Jun 2026: ROIC 1.3% (last 12 months) against a 9.7% cost of capital
QuarterROIC (12 months)ROE (12 months)Cost of capital
Sep 20231.8%5.3%9.7%
Dec 20231.9%7.4%9.7%
Mar 20242.1%9.5%9.7%
Jun 20242%8%9.7%
Sep 20241.9%6.2%9.7%
Dec 20241.9%8.1%9.7%
Mar 20251.3%8.1%9.7%
Jun 20251.9%6.8%9.7%
Sep 20252.2%8.5%9.7%
Dec 20250.1%0.1%9.7%
Mar 2026−2.9%−5.4%9.7%
Jun 20261.3%4.5%9.7%
ROIC and ROE over the last 12 months, each quarter, %; the flat line is the cost of capital. Last 12 quarters, lined up with the yearly figure.

Does ICON Public Limited have too much debt?

ICON Public Limited Company has total debt of $3.5 B against shareholder equity of $9.4 B as of Jun 2026, so its debt is 0.38× its equity. Year by year, that ratio went from 0.70 in FY21 to 0.38 in FY25. Keep that borrowing in mind when reading the returns on this page.

Debt-to-equity shows how much of the business is paid for with borrowed money. Lower is safer, and the direction matters as much as the level.

FY25: debt $3.6 B, 0.38× equity

  • Total debt $3.6 B
FY25: debt $3.6 B, 0.38× equity
QuarterTotal debt
FY21$5.6 B
FY22$4.8 B
FY23$3.9 B
FY24$3.6 B
FY25$3.6 B

Debt-to-equity

  • Debt-to-equity 0.38×
Debt-to-equity
QuarterDebt-to-equity
FY210.70×
FY220.57×
FY230.43×
FY240.38×
FY250.38×
Top: total debt each year, $ B. Below: debt-to-equity, ×. 5-year window.

Jun 2026: debt $3.5 B, debt-to-equity 0.38

  • Total debt (quarterly) $3.5 B
Jun 2026: debt $3.5 B, debt-to-equity 0.38
QuarterTotal debt (quarterly)
Sep 2023$4.2 B
Dec 2023$3.9 B
Mar 2024$3.7 B
Jun 2024$3.6 B
Sep 2024$3.6 B
Dec 2024$3.6 B
Mar 2025$3.6 B
Jun 2025$3.6 B
Sep 2025$3.6 B
Dec 2025$3.6 B
Mar 2026$3.5 B
Jun 2026$3.5 B

Debt-to-equity

  • Debt-to-equity 0.38×
Debt-to-equity
QuarterDebt-to-equity
Sep 20230.47×
Dec 20230.43×
Mar 20240.39×
Jun 20240.38×
Sep 20240.37×
Dec 20240.38×
Mar 20250.38×
Jun 20250.38×
Sep 20250.38×
Dec 20250.38×
Mar 20260.38×
Jun 20260.38×
Top: total debt each quarter, $ B. Below: debt-to-equity, ×. Last 12 quarters.

What is the ICON Public Limited shareholding pattern?

We have no ownership or short-position figures for ICON Public Limited Company, so this section says so rather than fill the gap. At normal trading volumes, closing those positions would take about 3.1 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead.

There is no quarter-by-quarter list of owners here, so we look at short interest: the share of tradable shares held in short positions, which gain if the price falls.

How far is ICON Public Limited from balance-sheet trouble?

For ICON Public Limited Company, the Z-score is 1.78. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is in the danger zone. It estimates how far the balance sheet is from trouble; it is not a forecast of failure.

The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.

Why it matters: a Z-score of 1.78 is inside the danger zone, so the balance sheet is a real risk.

How does ICON Public Limited rank in its industry?

37.9 out of 100, rank 27 of 30 in Diagnostics & Research, with 81% of the evidence available.

ICON Public Limited Company scores 37.9 out of 100 against the 30 companies it is compared with in Diagnostics & Research, ranking 27. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.

The four parts add up to the total exactly: 7.6 + 10.2 + 7.3 + 12.8 = 37.9. This is the same number shown on the industry page; it is worked out once for the whole group and read here.

What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector.

Which companies is ICON Public Limited compared with?

ICON Public Limited ranks 27 of 30 Diagnostics & Research companies on the 4-Factor Sector Score, with 37.9 out of 100.

  1. 1CareDx, Inc.CDNA · leader · Evidence leans up · 64% evidence62.8out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 25.1/35 · Revenue 33.9% · Profit 93.1% · Operating margin change 12.6 points · 62% evidenceCapital efficiency 7.2/25 · ROCE -0.4% · Operating margin 0.2% · 76% evidenceValuation 10.6/20 · P/E 13.3× · PEG — · 15% evidenceRelative strength 19.9/20 · Lead over its industry 102.6% · Lead over S&P 500 155% · 1 year 449.7% · 100% evidence · 12 of 12 weeks aheadExact sum: 25.1 + 7.2 + 10.6 + 19.9 = 62.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  2. 2Agilent Technologies, Inc.A · leader · Evidence leans up · 85% evidence61.6out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 20.8/35 · Revenue 8.6% · Profit 18% · Operating margin change 2.9 points · 95% evidenceCapital efficiency 18.4/25 · ROCE 15.4% · Operating margin 25.6% · 76% evidenceValuation 11.1/20 · P/E 27.1× · PEG 1.41 · 65% evidenceRelative strength 11.3/20 · Lead over its industry -9% · Lead over S&P 500 20.5% · 1 year 20.7% · 100% evidence · 12 of 12 weeks aheadExact sum: 20.8 + 18.4 + 11.1 + 11.3 = 61.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  3. 3Labcorp Holdings Inc.LH · leader · Evidence leans up · 81% evidence60.5out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 21.3/35 · Revenue 6.4% · Profit 31.2% · Operating margin change 0.9 points · 83% evidenceCapital efficiency 13.4/25 · ROCE 9.9% · Operating margin 12.2% · 76% evidenceValuation 15.2/20 · P/E 22.9× · PEG 0.69 · 65% evidenceRelative strength 10.6/20 · Lead over its industry -8.7% · Lead over S&P 500 21.7% · 1 year 45.5% · 100% evidence · 11 of 12 weeks aheadExact sum: 21.3 + 13.4 + 15.2 + 10.6 = 60.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  4. 4Medpace Holdings, Inc.MEDP · breaking out · Evidence leans up · 85% evidence59.7out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 19.1/35 · Revenue 20.3% · Profit 19.4% · Operating margin change 1.6 points · 95% evidenceCapital efficiency 21.3/25 · ROCE 75.3% · Operating margin 23.1% · 76% evidenceValuation 12.2/20 · P/E 33.6× · PEG 1.29 · 65% evidenceRelative strength 7.1/20 · Lead over its industry -13.8% · Lead over S&P 500 14.3% · 1 year 11.5% · 100% evidence · 11 of 12 weeks aheadExact sum: 19.1 + 21.3 + 12.2 + 7.1 = 59.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  5. 5IDEXX Laboratories, Inc.IDXX · turning · Evidence leans up · 81% evidence59.5out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 23.1/35 · Revenue 12.8% · Profit 15.5% · Operating margin change 1.4 points · 83% evidenceCapital efficiency 21.3/25 · ROCE 68.1% · Operating margin 35% · 76% evidenceValuation 7.1/20 · P/E 36.4× · PEG 1.97 · 65% evidenceRelative strength 8.0/20 · Lead over its industry -19.4% · Lead over S&P 500 8.7% · 1 year -1.5% · 100% evidence · 1 of 12 weeks aheadExact sum: 23.1 + 21.3 + 7.1 + 8 = 59.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  6. 6Revvity, Inc.RVTY · leader · Too little evidence to rank firmly · 58% evidence59.1out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 20.4/35 · Revenue — · Profit — · Operating margin change 3.3 points · 45% evidenceCapital efficiency 12.8/25 · ROCE 4.3% · Operating margin 17.1% · 76% evidenceValuation 8.8/20 · P/E 53.4× · PEG — · 15% evidenceRelative strength 17.1/20 · Lead over its industry 3.2% · Lead over S&P 500 36% · 1 year 75.6% · 100% evidence · 12 of 12 weeks aheadExact sum: 20.4 + 12.8 + 8.8 + 17.1 = 59.1 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose.
  7. 7GRAIL, Inc.GRAL · leader · Evidence leans up · 61% evidence56.2out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 22.9/35 · Revenue 23% · Profit — · Operating margin change 36.1 points · 62% evidenceCapital efficiency 3.9/25 · ROCE -19.3% · Operating margin -332% · 76% evidenceValuation 10.0/20 · P/E — · PEG — · 0% evidenceRelative strength 19.4/20 · Lead over its industry 27.8% · Lead over S&P 500 66% · 1 year 80.9% · 100% evidence · 12 of 12 weeks aheadExact sum: 22.9 + 3.9 + 10 + 19.4 = 56.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  8. 8Mettler-Toledo International Inc.MTD · leader · Evidence leans up · 81% evidence55.8out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 17.0/35 · Revenue 6.9% · Profit 9% · Operating margin change 3.8 points · 83% evidenceCapital efficiency 21.0/25 · ROCE 47.8% · Operating margin 31.2% · 76% evidenceValuation 6.8/20 · P/E 28.5× · PEG 2.27 · 65% evidenceRelative strength 11.0/20 · Lead over its industry -10.7% · Lead over S&P 500 19% · 1 year 19.7% · 100% evidence · 12 of 12 weeks aheadExact sum: 17 + 21 + 6.8 + 11 = 55.8 · What this means: A strong business with a high valuation: it would need rising earnings, or a lower multiple, to score better on value.
  9. 9Natera, Inc.NTRA · leader · Evidence leans up · 64% evidence54.7out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 24.1/35 · Revenue 37.8% · Profit — · Operating margin change 9.9 points · 62% evidenceCapital efficiency 5.3/25 · ROCE -13.5% · Operating margin -10.3% · 76% evidenceValuation 11.4/20 · P/E -152.2× · PEG — · 15% evidenceRelative strength 13.9/20 · Lead over its industry 8.4% · Lead over S&P 500 41.3% · 1 year 95.9% · 100% evidence · 12 of 12 weeks aheadExact sum: 24.1 + 5.3 + 11.4 + 13.9 = 54.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  10. 10Adaptive Biotechnologies CorporationADPT · leader · Evidence leans up · 64% evidence53.5out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 25.7/35 · Revenue 51.5% · Profit — · Operating margin change 20.5 points · 62% evidenceCapital efficiency 5.5/25 · ROCE -6.8% · Operating margin -22% · 76% evidenceValuation 10.9/20 · P/E -28.6× · PEG — · 15% evidenceRelative strength 11.4/20 · Lead over its industry 1.5% · Lead over S&P 500 32.3% · 1 year 80.6% · 100% evidence · 11 of 12 weeks aheadExact sum: 25.7 + 5.5 + 10.9 + 11.4 = 53.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  11. 11Quest Diagnostics IncorporatedDGX · leader · Evidence leans up · 85% evidence53.3out of 100GrowthCapitalValuationRelative
  12. 12Sotera Health CompanySHC · quiet · Evidence leans up · 71% evidence51.3out of 100GrowthCapitalValuationRelative
  13. 13Charles River Laboratories International, Inc.CRL · leader · Evidence leans up · 64% evidence50.2out of 100GrowthCapitalValuationRelative
  14. 14IQVIA Holdings Inc.IQV · leader · Evidence leans down · 81% evidence49.2out of 100GrowthCapitalValuationRelative
  15. 15BillionToOne, Inc.BLLN · turning · Too little evidence to rank firmly · 58% evidence49.1out of 100GrowthCapitalValuationRelative
  16. 16OPKO Health, Inc.OPK · turning · Evidence leans down · 64% evidence48.7out of 100GrowthCapitalValuationRelative
  17. 17Veracyte, Inc.VCYT · turning · Evidence leans down · 64% evidence48.6out of 100GrowthCapitalValuationRelative
  18. 18Danaher CorporationDHR · breaking out · Evidence leans down · 85% evidence48.4out of 100GrowthCapitalValuationRelative
  19. 19NeoGenomics, Inc.NEO · losing its lead · Evidence leans down · 64% evidence47.4out of 100GrowthCapitalValuationRelative
  20. 20Twist Bioscience CorporationTWST · leader · Evidence leans down · 64% evidence46.6out of 100GrowthCapitalValuationRelative
  21. 21Guardant Health, Inc.GH · turning · Evidence leans down · 61% evidence46.1out of 100GrowthCapitalValuationRelative
  22. 22RadNet, Inc.RDNT · breaking out · Evidence leans down · 64% evidence46.0out of 100GrowthCapitalValuationRelative
  23. 23Illumina, Inc.ILMN · leader · Evidence leans down · 71% evidence45.1out of 100GrowthCapitalValuationRelative
  24. 24Thermo Fisher Scientific Inc.TMO · leader · Evidence leans down · 85% evidence44.6out of 100GrowthCapitalValuationRelative
  25. 25Qiagen N.V.QGEN · breaking out · Evidence leans down · 81% evidence44.3out of 100GrowthCapitalValuationRelative
  26. 26Waters CorporationWAT · leader · Too little evidence to rank firmly · 58% evidence40.0out of 100GrowthCapitalValuationRelative
  27. 27ICON Public Limited Company this pageICLR · turning · Evidence leans down · 81% evidence37.9out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 7.6/35 · Revenue 3.7% · Profit -92.7% · Operating margin change -4.4 points · 83% evidenceCapital efficiency 10.2/25 · ROCE 2.3% · Operating margin 9.4% · 76% evidenceValuation 7.3/20 · P/E 245.3× · PEG 1.87 · 65% evidenceRelative strength 12.8/20 · Lead over its industry -5.2% · Lead over S&P 500 24.9% · 1 year 27.6% · 100% evidence · 8 of 12 weeks aheadExact sum: 7.6 + 10.2 + 7.3 + 12.8 = 37.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  28. 28Castle Biosciences, Inc.CSTL · breaking out · Evidence leans down · 64% evidence35.4out of 100GrowthCapitalValuationRelative
  29. 29Personalis, Inc.PSNL · turning · Most evidence points down · 61% evidence33.4out of 100GrowthCapitalValuationRelative
  30. 30GeneDx Holdings Corp.WGS · quiet · Most evidence points down · 71% evidence24.6out of 100GrowthCapitalValuationRelative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read.

The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section.

Related companies: Diagnostics & Research, all 30 compared on one page.

Which companies are close to ICON Public Limited in size?

ICON Public Limited is the 16th largest of 34 Diagnostics & Research companies on Sector Alpha by market value (scores of 4 November 2026). Just above it: Medpace Holdings, Inc., Revvity, Inc. and Charles River Laboratories International, Inc. Just below it: Qiagen N.V., Twist Bioscience Corporation and GRAIL, Inc.

Diagnostics & Research companies close in size

  1. Medpace Holdings, Inc. $18.4 billion
  2. Revvity, Inc. $17.8 billion
  3. Charles River Laboratories International, Inc. $15.6 billion
  4. ICON Public Limited Company $15.2 billion
  5. Qiagen N.V. $10.5 billion
  6. Twist Bioscience Corporation $8.9 billion
  7. GRAIL, Inc. $6.4 billion

All 34 Diagnostics & Research companies, largest first

Companies close in size in other industries

  1. The Carlyle Group Inc. $15.2 billion · Asset Management
  2. Assurant, Inc. $15.2 billion · Insurance - Property & Casualty
  3. ICON Public Limited Company $15.2 billion
  4. Solventum Corporation $15.2 billion · Medical Instruments & Supplies
  5. Clean Harbors, Inc. $15.2 billion · Waste Management

What else do people ask about ICON Public Limited?

What were ICON Public Limited's latest quarterly results?

ICON Public Limited Company reported revenue of $2.1 B and net profit of $72.6 M for the Jun 2026 quarter. Revenue rose 1.2% and profit fell 64.3% compared with a year earlier. Earnings per share were $0.94.

The operating margin was 9.4%, 4.4 percentage points lower than a year earlier (as of 4 November 2026).

What is ICON Public Limited's market cap?

ICON Public Limited Company's market capitalisation is $15.2 B at a stock price of $203.11. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 4 November 2026).

How is ICON Public Limited performing?

ICON Public Limited Company's share price has been stalling near its high for 20 weeks. In its latest quarter, revenue rose 1.2% and profit fell 64.3% compared with a year earlier.

Over the past 13 weeks it has done better than the S&P 500, for 3 weeks running (as of 4 November 2026).

Will ICON Public Limited's stock price go up?

This page does not forecast ICON Public Limited Company's stock price. What it shows instead: the stock price is $203.11, and it has been stalling near its high for 20 weeks.

Nobody can reliably say which way a price will move, and this site does not try (as of 4 November 2026).

Where is ICON Public Limited in its business cycle?

ICON Public Limited Company's FY25 operating margin was 5.2%, against a 5-year range of 5.2% to 12.7%: the low end of its own range, which is often where recoveries start. The latest quarter was 9.4%.

Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 4 November 2026).

What could break the ICON Public Limited story?

The main question: the share price moved +27.6% in a year while yearly earnings per share moved −69.0%. The difference came from the market paying a higher multiple.

On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 4 November 2026).

Is ICON Public Limited a stock worth studying right now?

What the numbers show: ICON Public Limited Company's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: whether earnings grow into a price that has already moved.

Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 4 November 2026).

Where do these numbers come from?

Sector Alpha, written by code from the published numbers. Data as of 4 November 2026.

Every chart on this page is drawn by code from the published figures, with no forecasts and no price opinions.

See the plain-text version of this page.

More lists

Every Sector Alpha list, grouped

X · Instagram · YouTube · About · Newsletter · Newsletter archive
This is research, not advice. We’re not SEBI-registered.